NCT06274047: PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- State
- Under way
- Phase
- Phase 3
- People
- 120 planned
- Started
- 10 Sep 2024
- Primary completion
- 30 Jun 2027
- Arms
- Arm 4
- Results
- None posted
- 23 Feb 2024: Trial registered
- 10 Sep 2024: Trial started